Clinical trial Recruiting at 1 site Observational

Registry of patients with diabetes and those at risk of developing it

Official title: Polish Registry of Diabetes - PL: Polski Rejestr Diabetologiczny (PolReD)

Run by Medical University of Bialystok · NCT04657367 · Data updated 2026-11-12

This study is creating a registry of people with diabetes, those at risk for it, and healthy individuals to see how their health data can help improve care recommendations.

More Diabetes trials

Quick facts

Study typeObservational
SexAll
Enrollment10000 (estimated)
SponsorMedical University of Bialystok
Academic / other
Locations1 site (Bialystok, Podlaskie Voivodeship)
StatusRecruiting
StartedFebruary 3, 2020
Main results expectedDecember 31, 2030
Study endsDecember 31, 2030
Registry record updatedMarch 26, 2025
Trial IDNCT04657367 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients with diagnosed diabetes, prediabetes, and normoglycemic individuals willing to participate.

Probably not a fit

Patients with drug addiction, severe psychiatric disorders, or gestational diabetes may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to create a comprehensive registry of patients diagnosed with diabetes, those at high risk of developing diabetes, and a control group of normoglycemic individuals. Participants will undergo a detailed medical interview and provide biological samples for various omics analyses, which will be evaluated using artificial intelligence algorithms. The findings will lead to new care recommendations tailored for high-risk patients and those already suffering from diabetes. The study will be conducted at the Clinical Research Center of the Medical University of Bialystok.

Why it matters

Potential benefit: If successful, this registry could lead to improved care recommendations and management strategies for patients with diabetes and those at risk.

How similar studies have gone: Other studies have successfully utilized registries and omics data to improve diabetes care, indicating a promising approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients with diagnosed diabetes (according to the American Diabetes Association criteria) - diabetes group
* patients with diagnosed prediabetes (IFG and/or IGT) - prediabetes group
* patients with normoglycemia (NFG and NGT) - normoglycemia group
* informed consent

Exclusion Criteria:

* drug addiction
* severe psychiatric disorders
* patients with gestational diabetes mellitus
* patients unable to give informed consent, legally incompetent or incapable to comply with the study terms and conditions

Where it's running

  • Clinical Research Centre, Medical University of Bialystok
    Bialystok, Podlaskie Voivodeship, Poland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.